tegoprubart
Phase 2- Indications
- Amyotrophic Lateral Sclerosis (ALS)
Company intelligence / Profile preview
ALS Therapy Development Institute
Cambridge, Massachusetts, United Statesals.net ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Phase 2
01
Overview
ALS Therapy Development Institute has developed several preclinical candidates for ALS. Its most advanced asset, AT‑1501, a monoclonal antibody targeting CD40L/CD154, has entered clinical testing as a potential treatment for ALS. The institute also runs large-scale patient data initiatives like the Precision Medicine Program/ALS Research Collaborative to accelerate discovery and development of new therapeutics[5][8].
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesProtein biologicsGene therapiesCell-based constructs
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
1 asset03
Partnerships
Muscular Dystrophy Association (“Augie’s Quest” initiative)Regenesance (Netherlands)Neurotune (Switzerland)Gladstone Institutes (USA)various academic collaborations
Beyond the preview
Go deeper on ALS Therapy Development Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALS Therapy Development Institute.